Effects of Smoking Addiction on Lower Limb Speed and Coordination

NCT ID: NCT07061522

Last Updated: 2025-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-26

Study Completion Date

2026-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational case-control study will investigate the impact of smoking addiction on lower extremity speed and coordination in young adults. Participants aged 18-25 will be divided into two groups based on their smoking status. The study will compare motor coordination and sprint performance between smokers and non-smokers using objective physical tests under standardized laboratory conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This non-randomized controlled study will aim to evaluate the effects of smoking addiction on the speed and coordination of lower extremity movements among healthy young adults. Smoking is known to have detrimental effects on vascular, musculoskeletal, and neurological systems, yet its impact on motor performance-particularly in the lower limbs-has not been sufficiently studied.

Participants aged 18-25 will be categorized into smoker and non-smoker groups based on DSM-IV-TR nicotine dependence criteria and the Fagerström Test. The Lower Extremity Motor Coordination Test (LEMOCOT) will be used to assess motor coordination, while a 30-meter sprint test will evaluate movement speed. Additionally, body mass index (BMI) and bimalleolar diameter and circumference will be recorded to control for confounding physical variables.

All assessments will be conducted in a controlled laboratory environment. The results will be analyzed to determine whether smoking addiction is associated with impaired lower limb motor function. The findings may provide new insights into the functional consequences of smoking in young adults and contribute to the design of preventive and rehabilitative strategies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Smoking Addiction Group

Participants in this group will be individuals who meet the criteria for smoking addiction based on both the DSM-IV-TR criteria and the Fagerström Test for Nicotine Dependence. They must have smoked at least one cigarette per day for the past 12 months.

Behavioral/Physical Assessment

Intervention Type OTHER

This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.

Non-Smokers

Participants in this group will be healthy individuals aged 18-25 with no history of smoking within the past year. They will be matched in terms of age and BMI to the smoking group and will serve as the control cohort.

Behavioral/Physical Assessment

Intervention Type OTHER

This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral/Physical Assessment

This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Smoking ≥1 cigarette daily for at least 12 months
* Age between 18-25
* Literate and cooperative
* BMI: 18.5-29.9 kg/m²

Exclusion Criteria

* Orthopedic, neurological, or neuromuscular conditions impairing walking
* Chronic pulmonary or cardiac disease
* Cognitive impairment
* BMI ≥30 kg/m²
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ESRA PEHLIVAN

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Esra Pehlivan

Istanbul, Üsküdar, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Esra Pehlivan, Associate Professor

Role: CONTACT

+90216 777 87 77

Edanur Kocakaplan

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ESRA PEHLİVAN

Role: primary

02164189616

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Smoking Add-Coordination-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile Sensing of Smoking Behavior
NCT02116283 COMPLETED NA
Early Tobacco Abstinence - 5
NCT00224965 TERMINATED PHASE1
Mobile Contingency Management for Smoking Cessation
NCT04881630 ACTIVE_NOT_RECRUITING NA